Bollino, Dominique
Woodard, Nathaniel
Tighe, Kayla M.
Ma, Xinrong
Casildo, Andrea
D’Adamo, Christopher R.
Emadi, Ashkan
Knott, Cheryl L. http://orcid.org/0000-0002-2261-7875
Funding for this research was provided by:
Maryland Department of Health’s Cigarette Restitution Fund Program
National Cancer Institute (P30CA134274)
Article History
Received: 5 May 2023
Accepted: 20 September 2023
First Online: 9 October 2023
Declarations
:
: AE has received research grants from Jazz Pharmaceuticals, Amgen, NewLinks, and Servier. AE is a global oncology advisory board member for Amgen and has served as an advisory board member for Genentech, Servier, Kite Pharma, and Secura Bio. AE is a Co-Founder and Scientific Advisors for KinaRx, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All experimental protocols were approved by the University of Maryland Baltimore Institutional Review Board and Institutional Biosafety Committee (Protocol 1817227-3). For all animal studies, mice were housed under pathogen-free conditions in a University of Maryland Baltimore Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited facility. All experiments were conducted in compliance with Public Health Service (PHS) guidelines for animal research and approved by University of Maryland Baltimore Institutional Animal Care and Use Committee (Protocol 1021001).
: Not applicable (no participant identifers are included).
: Informed consent was obtained from all individual participants for study participation.